NAD+ dosing schedule
Human schedule
A subcutaneous reference generalized from longevity-practice protocols; controlled clinical data on NAD+ are limited. Start at a lower dose to assess tolerance, then increase if needed.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (tolerance) | 50 mg subcutaneously | Starting dose |
| Loading, 4–8 weeks | 50–100 mg, 2–3× weekly | Increase if tolerated |
| Maintenance | 100 mg, 1–2× weekly | Maximum in this schedule |